- News & insights/
- Consilium news/
- Consilium Strategic Communications advises Clinigen on successful...
11th May 2022
Consilium Strategic Communications advises Clinigen on successful acquisition by Triton
London, 11 May 2022, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to have supported Clinigen on its successful acquisition by Triton Funds, Triley Bidco Limited (“Triton”) for £1.3 billion ($1.7 billion). Consilium continues to advise Clinigen as a privately held company.
Consilium has advised Clinigen since May 2021, providing strategic corporate and financial communications guidance and support including positioning and messaging, media and financial markets relations, and reputation and issues management.
During the course of its work with Clinigen, Consilium advised the Board and executive management team on creating a strategic and integrated communication strategy to foster constructive engagement with all key stakeholders. In addition, Consilium advised Clinigen on its communications during the process of its successful acquisition by Triton.
Mary-Jane Elliott, Managing Partner of Consilium Strategic Communications, commented: “Clinigen is a leading provider of services to the global healthcare ecosystem, and we have been proud to support them since May 2021, culminating in the successful acquisition by Triton. We look forward to continuing to work with Clinigen as they create value by providing the right medicine to the right patient at the right time.”
The Consilium team advising Clinigen is Mary-Jane Elliott, Matthew Cole, Jessica Hodgson, Melissa Gardiner, Usman Sherani and Alex Gunter.
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. Consilium's team, based in both Europe and US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, international media management, transactions and healthcare stakeholder challenges. Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to
discrete specialist reputation management projects. For more information please see www.consilium-comms.com
Clinigen is a global, specialist pharmaceutical services and products company focused on providing ethical access to medicines. Its’ mission is to deliver the right medicine to the right patient at the right time.
Clinigen operates from sites in North America, Europe, Africa and the Asia Pacific and has more than 1,000 employees across five continents in 14 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. Clinigen currently works with more than 30 of the top 50 pharmaceutical companies and supplies medicines into more than 120 countries.
For more information on Clinigen, please visit http://www.clinigen.com
Since its establishment in 1997, Triton has sponsored ten funds, focusing on businesses in the industrial tech, services, consumer and healthcare sectors. The Triton funds invest in and support the positive development of medium-sized businesses headquartered in Europe.
Triton seeks to contribute to the building of better businesses for the longer term. Triton and its executives wish to be agents of positive change towards sustainable operational improvement and growth.
The 49 companies currently in Triton's portfolio have combined sales of around EUR 18 billion and employ around 104,000 employees. For more information: www.triton-partners.com